Myrbetriq ER 50 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB26FPLHZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,752
Award facts
- Contract value 100% obligated
- $13,751.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Myrbetriq ER 50 mg with a contract value of $13,751.50. The award, issued on October 22, 2025, represents a firm fixed-price delivery order with an ultimate completion date of October 23, 2025. This non-set-aside award was competitively awarded and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Myrbetriq is a prescription medication used to treat overactive bladder, and this order supports the federal government's pharmaceutical supply chain for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies across multiple therapeutic domains to support Department of Defense healthcare programs. The parent IDC serves as a flexible contract vehicle enabling the company to fulfill diverse pharmaceutical procurement needs for military healthcare systems worldwide, with additional planned regional awards anticipated under the DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative.
Quick answers
Who was awarded contract SPE2DB26FPLHZ?
SPE2DB26FPLHZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FPLHZ worth?
The government has obligated $13,752 on SPE2DB26FPLHZ.
Is contract SPE2DB26FPLHZ an order under another contract?
Yes. SPE2DB26FPLHZ is a delivery order under SPE2DB20D2001, an indefinite delivery contract.
Was contract SPE2DB26FPLHZ competed?
The extent of competition for SPE2DB26FPLHZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award